Related Experiment Video
Updated: Dec 12, 2025

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Bortezomib Plus Melphalan-Induced Cardiomyopathy Presenting as Sinus Tachycardia and Systolic Heart Failure
Parth J Sampat1, Sana Riaz1, Fidel Martinez2
1Internal Medicine, State University of New York Upstate Medical University, Syracuse, USA.
Abstract:
Chemotherapy-induced cardiotoxicity is a known condition, however, bortezomib and melphalan do not typically cause cardiotoxicity. With the rise in the use of newer chemotherapeutic agents, it is important to identify and understand the cardiac implications of chemotherapeutic agents. We present a case of a 70-year-old female with no known significant cardiac history presenting with partially reversible cardiomyopathy with initial presentation only being as sinus tachycardia.
More Related Videos
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
Heart Failure III: Clinical Manifestations

